...
首页> 外文期刊>Cellular oncology >Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology.
【24h】

Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology.

机译:使用组织活检对B细胞淋巴瘤进行蛋白分析:病理学中小样本的潜在工具。

获取原文
获取原文并翻译 | 示例
           

摘要

Non-Hodgkin's lymphoma comprises many related but distinct diseases and diagnosis and classification is complex. Protein profiling of lymphoma biopsies may be of potential value for use in this lymphoma classification and the discovery of novel markers. In this study, we have optimized a method for SELDI-TOF MS based protein profiling of frozen tissue sections, without dissection of tumour cells. First we have compared chip surfaces and lysis buffers. Also, we have determined the minimal input using laser dissection microscopy. Subsequently, we have analyzed and compared protein profiles of diffuse large B-cell lymphoma (n=8), follicular lymphoma (n=8) and mantle cell lymphoma (n=8). Benign, reactive lymph nodes (n=14) were used as a reference group.CM10 chip surface in combination with urea lysis buffer and an input of approximately 50,000 lymphocytes allowed the detection of many differential peaks. Identification of the diffuse large B-cell lymphoma cases was reliably made in the supervised classification. Unsupervised clustering showed segregation into a benign/indolent cluster predominantly formed by benign, reactive lymph nodes and follicular lymphoma cases and into a more aggressive cluster formed by diffuse large B-cell lymphoma and mantle cell lymphoma cases. In conclusion, our protocol enables protein profiling of protein lysates derived from small histological samples and the subsequent detection of many differentially expressed proteins, without the need of tumour cell dissection. These results support further evaluation of protein profiling of small lymphoma biopsies as an additional tool in pathology.
机译:非霍奇金淋巴瘤包括许多相关但截然不同的疾病,诊断和分类很复杂。淋巴瘤活检的蛋白质谱分析可能在这种淋巴瘤分类和发现新标志物方面具有潜在价值。在这项研究中,我们优化了一种基于SELDI-TOF MS的冷冻组织切片蛋白质谱分析方法,无需解剖肿瘤细胞。首先,我们比较了芯片表面和裂解缓冲液。此外,我们已经确定了使用激光解剖显微镜的最小输入量。随后,我们分析并比较了弥漫性大B细胞淋巴瘤(n = 8),滤泡性淋巴瘤(n = 8)和套细胞淋巴瘤(n = 8)的蛋白质谱。良性反应性淋巴结(n = 14)作为参照组。CM10芯片表面结合尿素裂解缓冲液和大约50,000个淋巴细胞的输入使得可以检测到许多差异峰。在监督分类中,可靠地确定了弥漫性大B细胞淋巴瘤病例。无监督的聚类显示分离成主要由良性,反应性淋巴结和滤泡性淋巴瘤病例形成的良性/惰性簇,并分离成由弥散性大B细胞淋巴瘤和套细胞淋巴瘤病例形成的更具侵略性的簇。总而言之,我们的方案能够对来自小的组织学样品的蛋白质裂解物进行蛋白质谱分析,并随后检测许多差异表达的蛋白质,而无需进行肿瘤细胞解剖。这些结果支持进一步评估小淋巴瘤活检的蛋白质谱,作为病理学中的其他工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号